Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
INLIF LIMITED, a developer and manufacturer of injection molding machine-dedicated manipulator arms, is entering the humanoid robotics market. The company highlighted its progress in R&D with a humanoid robot demonstrating advanced motion capabilities such as somersaults and dynamic balance. INLIF plans to focus on high-dynamic motion control, core…
Kaltura has been named a Leader in The Aragon Research Globe for Enterprise Video, 2026, highlighting its flexible, enterprise-grade video platform enhanced with AI-driven Agentic Avatars. The platform supports personalized, real-time interactions across multiple enterprise use cases including communications, learning, events, and marketing. Recent…
One Stop Systems, a Nasdaq-listed leader in rugged high-performance computing for AI and edge applications, announced the appointment of Paul 'PK' Averna as Vice President Business Development and Growth. Averna brings over 30 years of experience in defense and commercial technology markets, expected to accelerate OSS's expansion and deepen custome…
Denali Therapeutics announced an agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $195 million. The PRV was awarded following FDA accelerated approval of their enzyme replacement therapy AVLAYAH, the first FDA-approved biologic designed to cross the blood-brain barrier. Proceeds will support advancement of Denali's Tra…
Abercrombie & Fitch Co.'s Hollister brand is expanding beyond apparel into home and dorm decor through a multi-season collaboration with Target, featuring nearly 60 items including bedding and wearable accessories. The collection aims to meet evolving lifestyle needs and will be available online and in stores starting June 28, 2026.
Enphase Energy began shipments of its new IQ9S-3P Commercial Microinverter built with advanced gallium nitride (GaN) technology. This product supports high-wattage solar panels up to 770 W and three-phase 480Y/277 V grid configurations, offering improved efficiency (97.5%) and cooler operation. Manufactured in the U.S., it may qualify for federal t…
Allegro MicroSystems has appointed Brian C. White, an experienced semiconductor industry CFO and board member, to its Board of Directors as an independent director. White's expertise in financial strategy, governance, and corporate development is expected to support Allegro's growth especially in AI data center, robotics, and automotive sectors.
WISeKey International Holding Ltd announced that its WISe.ART subsidiary has become the world's first hardware-authenticated art platform. SEALSQ, another WISeKey subsidiary, secured a European Patent for 'Back-to-Physical' NFT technology that embeds NFTs directly into secure semiconductors, creating an immutable link between digital assets and phy…
Allarity Therapeutics (NASDAQ: ALLR), a clinical-stage biopharmaceutical company, announced the presentation of a Trial-in-Progress poster on their ongoing Phase 2 study of stenoparib, a novel dual PARP and WNT pathway inhibitor, for advanced platinum-resistant or platinum-ineligible ovarian cancer. The presentation at the ESMO Gynaecological Cance…
Grace Therapeutics announced its fiscal year 2026 financial results and business updates, focusing on the planned NDA resubmission for GTx-104 following a Complete Response Letter from the FDA citing Chemistry, Manufacturing, and Controls issues. The company is preparing for a Type A meeting with the FDA to clarify the path forward and continues pr…
ZenaTech, Inc. announced the unveiling of Zoo Office™, a unified AI-powered productivity platform designed to unify and enhance its enterprise SaaS ecosystem and capitalize on the fast-growing Agentic AI market. The platform aims to automate workflows, enhance decision-making, and reduce software sprawl by providing an intelligent, connected busine…
Bionano Genomics announced a significant 67% increase in studies featuring its optical genome mapping technology at the 2026 European Society of Human Genetics conference compared to 2025. The expanded usage spans 17 countries across five global markets and covers diverse genetic research areas such as rare disorders, cancers, and cardiovascular ge…
Aterian, Inc. informed its stockholders about the mailing of proxy materials in advance of a Special Meeting on July 10, 2026. The meeting will cover approval of an $18 million asset sale of its marquee e-commerce brands to Trademark Global, and a $7 million preferred stock investment from strategic investor David E. Lazar. Proceeds from the asset …
Trio Petroleum Corp provides an update on its acquisition efforts focused primarily on oil and gas properties in Alberta and Saskatchewan, Canada. The company holds a strong cash position with no long-term debt, enabling financial flexibility to pursue acquisitions that meet strict technical and economic criteria. Trio has submitted multiple acquis…
RoboStrategy, Inc., a Nasdaq-listed closed-end fund focused on robotics and physical AI private companies, completed private placements raising approximately $28.9 million by issuing 797,434 shares at an average price of $36.28. The Fund aims to continue capital raises to invest in venture-backed robotics and embodied AI companies, bridging public …
BioCardia announces its focus for 2026 on submitting CardiAMP Cell Therapy for ischemic heart failure approval to Japan's PMDA, aiming for initial approval for a 20,000-patient subgroup. The company highlights its clinical trial enrollment progress in the US, innovative delivery platform partnerships, and plans for strategic collaborations around i…
Prime Medicine announced that New Zealand's regulatory authority approved its clinical trial application for PM577a, the company's investigational Prime Editor therapy for Wilson Disease targeting the H1069Q ATP7B gene mutation. This clearance marks the first clinical authorization for Prime Medicine's in vivo Prime Editing treatment, enabling a gl…
Byrna Technologies' CEO Conn Davis shares a detailed letter updating shareholders on his initial 100 days in leadership, focusing on expanding retail and e-commerce presence, shifting marketing from weapon-focused to safety-first messaging, enhancing customer education, and improving operational efficiency. The company aims to broaden its customer …
BIO-key International announced that its CEO Michael DePasquale will participate in a Maxim Group Defense Tech Virtual Conference webcast to discuss the company's success in biometric authentication solutions, particularly with military and defense customers. The company expects a 50% revenue increase and profitability in the first half of 2026, si…
U.S. markets face the largest options expiration on record on Thursday, June 18, with about $8.3 trillion in options exposure set to expire in a single session - roughly 18% more than the previous high of about $7.1 trillion in December 2025. The event - pushed one day earlier because markets are closed Friday for Juneteenth - coincides with quarte…
Moderna shares climbed after an FDA advisory committee convened to assess whether the benefits of the company’s mRNA influenza vaccine exceed its risks for older adults. The FDA review comes after regulators reversed an earlier rejection of the application. Moderna is seeking full approval for ages 50-64 and accelerated approval for those 65 and ol…
UniCredit appointed Riccardo Orcel - a former senior banker at Russian state-backed VTB Group and brother of the bank's CEO Andrea Orcel - as an independent adviser after he presented a proposal that led to a non-binding agreement to sell parts of UniCredit's Russia business to a private investor based in the United Arab Emirates. Orcel has since l…
Clearmind Medicine Inc., a clinical-stage biotech company specializing in non-hallucinogenic neuroplastogen-derived therapeutics, announced that it has been granted a U.S. patent for its molecule MEAI related to regulating binge behaviors such as excessive drinking, eating, and gambling. This patent strengthens the company's intellectual property p…
UBS increased its weighting in industrial metals from moderately overweight to overweight, while trimming its energy allocation from overweight to moderately overweight. The bank points to a price pullback in base metals as an entry point amid structural demand and supply constraints, but warns of ongoing near-term volatility. Precious metals remai…
U.S. equity futures rose on Thursday as markets reacted to news of an interim Middle East peace agreement that appeared to reduce some of the market's anxieties tied to the Federal Reserve's hawkish posture. At 0750 ET (11:50 GMT) futures contracts showed modest gains, with technology names among the strongest premarket performers. Several individu…
